DAWN vs SGEN
Day One Biopharmaceuticals Inc (DAWN) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
SGEN (SGEN) common stock.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
SGEN does not have a complete income-statement cache yet.
DAWN currently screens at market cap $656.8M.
Not investment advice. Open the DAWN and SGEN stock pages for the full models.
Not investment advice.